A detailed history of Ifp Advisors, Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 22,520 shares of FOLD stock, worth $220,696. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,520
Previous 22,312 0.93%
Holding current value
$220,696
Previous $262,000 14.89%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$9.04 - $11.75 $1,880 - $2,444
208 Added 0.93%
22,520 $223,000
Q1 2024

Jul 30, 2024

BUY
$11.43 - $14.24 $7,818 - $9,740
684 Added 3.16%
22,312 $262,000
Q4 2023

Jan 09, 2024

BUY
$9.97 - $14.52 $15,204 - $22,143
1,525 Added 7.59%
21,628 $306,000
Q3 2023

Oct 12, 2023

SELL
$11.78 - $13.86 $179,974 - $211,753
-15,278 Reduced 43.18%
20,103 $244,000
Q2 2023

Aug 04, 2023

SELL
$10.72 - $13.3 $4,384 - $5,439
-409 Reduced 1.14%
35,381 $444,000
Q1 2023

Apr 18, 2023

SELL
$10.91 - $13.54 $12,917 - $16,031
-1,184 Reduced 3.2%
35,790 $396,000
Q4 2022

Feb 07, 2023

BUY
$9.89 - $12.7 $53,218 - $68,338
5,381 Added 17.03%
36,974 $610,000
Q3 2022

Nov 08, 2022

BUY
$9.82 - $12.75 $7,914 - $10,276
806 Added 2.62%
31,593 $519,000
Q2 2022

Sep 06, 2022

BUY
$6.23 - $11.12 $191,803 - $342,351
30,787 New
30,787 $505,000
Q2 2022

Aug 12, 2022

SELL
$6.23 - $11.12 $191,803 - $342,351
-30,787 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$7.89 - $12.48 $141,728 - $224,178
17,963 Added 140.07%
30,787 $291,000
Q1 2022

Aug 08, 2022

BUY
$7.89 - $12.48 $1,049 - $1,659
133 Added 1.05%
12,824 $121,000
Q4 2021

Jan 12, 2022

BUY
$9.82 - $12.44 $20,533 - $26,012
2,091 Added 19.73%
12,691 $143,000
Q3 2021

Oct 06, 2021

SELL
$8.74 - $11.84 $13,791 - $18,683
-1,578 Reduced 12.96%
10,600 $102,000
Q2 2021

Jul 13, 2021

BUY
$8.71 - $10.72 $1,724 - $2,122
198 Added 1.65%
12,178 $118,000
Q1 2021

Apr 30, 2021

BUY
$9.2 - $23.86 $103,665 - $268,854
11,268 Added 1582.58%
11,980 $119,000
Q4 2020

Jan 25, 2021

BUY
$13.47 - $24.89 $7,516 - $13,888
558 Added 362.34%
712 $15,000
Q3 2020

Oct 29, 2020

BUY
$12.89 - $15.89 $1,985 - $2,447
154 New
154 $2,000
Q2 2020

Aug 05, 2020

BUY
$8.86 - $15.69 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

BUY
$6.63 - $11.16 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020

BUY
$7.48 - $10.75 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019

BUY
$8.02 - $13.25 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

SELL
$10.04 - $13.92 $210 - $292
-21 Closed
0 $0
Q3 2018

Oct 25, 2018

SELL
$11.6 - $16.54 $800 - $1,141
-69 Reduced 76.67%
21 $0
Q2 2018

Aug 07, 2018

BUY
$13.13 - $17.09 $905 - $1,179
69 Added 328.57%
90 $0
Q4 2017

Jan 24, 2018

SELL
$12.51 - $16.24 $15,012 - $19,487
-1,200 Reduced 98.28%
21 $0
Q3 2017

Oct 30, 2017

SELL
$11.74 - $15.78 $11,493 - $15,448
-979 Reduced 44.5%
1,221 $18,000
Q2 2017

Jun 03, 2019

BUY
N/A
2,000 Added 1000.0%
2,200 $22,000
Q2 2016

Jun 03, 2019

BUY
N/A
200
200 $1,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.75B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.